Dr Solitaire: Assessing Cognitive Performance Through Meaningful Play
Observational Study to Assess Cognitive Performance in Elderly Life Via Meaning Play
1 other identifier
observational
30
1 country
2
Brief Summary
To assess cognitive performance by means of the game of Solitaire. In this study, the investigators want to define relevant game metrics, when playing Solitaire, that may be indicative of cognitive performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2017
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2016
CompletedFirst Posted
Study publicly available on registry
November 22, 2016
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJuly 3, 2024
July 1, 2024
4.4 years
November 9, 2016
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Specification of Cognitive Performance Metrics for the game Solitaire
From this study, metrics will be defined which can measure cognitive performance in cardgames like Solitaire. Possible candidates are, but are not limited to: situational awareness to measure visual perception and performance on dual tasks to measure divided attention. A more detailed table of possible game metrics of cognitive performance can be found in H. B. Jimison, M. Pavel, P. Bissell, and J. McKanna, "A Framework for Cognitive Monitoring Using Computer Game Interactions," Medinfo 2007 Proc. 12th World Congr. Health Med. Inform. Build. Sustain. Health Syst., p. 1073, 2007.
1 day
Secondary Outcomes (1)
Design Guidelines Apps for the Elderly
1 day
Study Arms (2)
Healthy Elderly
Mild Cognitive Impaired Elderly
Eligibility Criteria
24-30 participants, both cognitively healthy older persons (n = 12-15) as well as older persons with mild cognitive impairment (MCI) or mild Alzheimer's disease (mAD) (12-15)
You may qualify if:
- For the HEALTHY participants
- The participant has a minimum age of 65 years.
- The participant is living independently or semi-independently at home, service flat or care home.
- The participant has no subjective memory concern as reported by the participant, informant, or clinician.
- The participant has a normal brain function documented by scoring above 27 on the MMSE, above 26 on the MOCA and has a score of 0 for the CDR.
- In the opinion of the investigator, the participant is in stable medical condition and willing and able to perform study procedures in the opinion of the investigator.
- The participant is fluent in written and verbal Dutch.
- For the participants with COGNITIVE IMPAIRMENT:
- The participant has a minimum age of 65 years.
- The participant is living independently or semi-independently at home, service flat or care home.
- In the opinion of the investigator, the participant is in stable medical condition and willing and able to perform study procedures in the opinion of the investigator.
- The participant is fluent in written and verbal Dutch.
- For MCI: MCI patients, at baseline, are diagnosed applying Petersen's diagnostic criteria, i.e., (1) cognitive complaint, preferably corroborated by an informant; (2) objective cognitive impairment, quantified as performance of more than 1.5 SD below the appropriate mean on the neuropsychological subtests (z-score below -1.5); (3) largely normal general cognitive functioning; (4) essentially intact activities of daily living (ADL) (basic and instrumental activities of daily living (iADL) were determined by a clinical interview with the patient and an informant); and (5) not demented.
- For AD:Probable AD according to the National Institute on Aging/Alzheimer's Association Diagnostic Guidelines
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- KU Leuvencollaborator
Study Sites (2)
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
University Hospital Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Related Publications (1)
Gielis K, Vanden Abeele ME, De Croon R, Dierick P, Ferreira-Brito F, Van Assche L, Verbert K, Tournoy J, Vanden Abeele V. Dissecting Digital Card Games to Yield Digital Biomarkers for the Assessment of Mild Cognitive Impairment: Methodological Approach and Exploratory Study. JMIR Serious Games. 2021 Nov 4;9(4):e18359. doi: 10.2196/18359.
PMID: 34734825DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vero Vanden Abeele, prof.
KU Leuven
- PRINCIPAL INVESTIGATOR
Karsten Gielis, Drs.
KU Leuven
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2016
First Posted
November 22, 2016
Study Start
December 1, 2017
Primary Completion
May 1, 2022
Study Completion
March 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07